je.st
news
Medivation and Astellas Announce Final Results from the Phase 3...
2014-01-29 01:40:26| Logistics - Topix.net
Study demonstrates statistically significant benefits in overall survival, radiographic progression-free survival, and a delay in the time to initiation of chemotherapy-- Medivation Inc. and Astellas Pharma Inc. announced final results on the primary and secondary efficacy endpoints from the Phase 3 PREVAIL trial of enzalutamide in patients with ... (more)
Tags: the
results
final
phase
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|
|||||||||||||||||||